BIO Asia–Taiwan 2025 亞洲生技大會

09:00 – 10:30

Plenary Session 1 – Global Biotech Development

The imposition of import tariffs and their effects on global trade are threatening to upend essential cross-border supply chains that the biomedical industries are built on. Plenary Session 1 gathers biotech leaders from Asia and around the world to discuss this and other topics important to the industry, including Taiwan's role in today's biotech industry; the current state of international collaborations; and the biotech industry's strategic importance, both now and in the future. The highlight of the session will be the Tang Prize Lecture featuring Jens Juul Holst and spotlighting his groundbreaking work on GLP-1, a discovery transforming diabetes treatment and metabolic health worldwide.

09:00 – 09:05

Conference Opening

Welcoming Remarks

Johnsee Lee, Chairman of BIO Asia–Taiwan 2025; Honorary Chairman, Taiwan Bio Industry Organization (Taiwan BIO)
Lee-Cheng Liu, Chairman, Taiwan Bio Industry Organization

09:05– 09:10

Session Chair

Lee-Cheng Liu, Chairman, Taiwan Bio Industry Organization

Greetings from BIO

Kelly Seagraves, Vice President for National Security and International Affairs, Biotechnology Innovation Organization (BIO)

09:10– 09:30

BIO Asia Award Lecture
To Build Well-educated, Healthy Middle Class by Establishing Technology Industry

George Hara, 2024 BIO Asia Award Recipient; Group Chairman & CEO, DEFTA Partners; Chairman of Board, Alliance Forum Foundation (Organization in Special Consultative Status with the UN Economic and Social Council)

09:30– 09:50

Topic TBD

Claire Skentelbery, Chair, The International Council of Biotechnology Associations (ICBA); Director General, EuropaBio

09:50 – 10:10

Biotechnology Without Borders: Unlocking the Future Through Innovation and Collaboration

My Linh KHA, Senior Vice President and General Manager, Japan Asia-Pacific, Amgen

10:10 – 10:30

Tang Prize Lecture

GLP-1 Discovery and Recent Results with GLP-1 Receptor Agonists (GLP-1RAs)

Jens Juul Holst, Tang Prize Laureate; Professor of Medical Physiology; The Novo Nordisk Foundation Center for Basic Metabolic Research and Department of Biomedical Sciences, University of Copenhagen

10:30 – 11:50

Plenary Session 2 – Global Biotech Development

Continuing with the themes of Session 1, Plenary Session 2 highlights transformative biotech strategies shaping the Asia-Pacific region and beyond. Discussions will cover how to advance regional innovation and patient access; how genomics is redefining the future of healthcare and life sciences investment, as well as other highly-pertinent topics. The session promises dialogue at the intersection of science, policy, and business, providing a forward-facing perspective on biotech’s evolving impact and global potential.

10:30 – 10:50

TEAMNOVATION: The Key to Advancing OMTX705 From Lab to Clinic

Manuel Sanz, COO, Oncomatryx Biopharma

10:50 – 11:10

Biotech’s Complex Moment

David Flores, Co-Founder, President & CEO, BioCentury

11:10 – 11:30

From Science Fiction to Reality: Capitalising on the Genomic Revolution

Nick Meadows, Pharma, MedTech and Life Sciences Sector Leader in PwC Australia

11:30 – 11:50

Beyond Guesswork: Using AI to Forecast and Optimize Clinical Trials

Rostina Yoon, Neuroscience Strategy and Delivery, Vice President, Clinical Solutions, Syneos Health

12:00 – 13:20

Plenary Session 3 – The Value of Innovation for a Healthier Taiwan

Plenary Session 3 is Taiwan-focused, and will explore how innovation drives public health and sustainable growth on the island. The session will emphasize Taiwan’s strategic role in the life sciences ecosystem, highlighting policy frameworks fostering innovation and accessibility. Thought leaders from the pharmaceutical, biotech, and healthcare sectors will examine the current state of local R&D, current levels of digital transformation in Taiwan, and recent cross-sector collaboration. Discussion will also delve into aligning innovation with healthcare equity and long-term societal value. This session reinforces the critical link between scientific advancement and a healthier, more resilient Taiwan.

12:00 – 12:05